verapamil has been researched along with nsc 259,968 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adwankar, MK; Chitnis, MP | 1 |
| Adwankar, MK; Basrur, VS; Chitnis, MP; Menon, RS; Satyamoorthy, K | 1 |
2 other study(ies) available for verapamil and nsc 259,968
| Article | Year |
|---|---|
Enhancement of the in vitro cytotoxicity of bouvardin by verapamil alone and combined with hyperthermia in Sarcoma 180 and Ehrlich ascites carcinoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Cell Line; Cell Membrane Permeability; Combined Modality Therapy; DNA; Drug Resistance; Drug Synergism; Hyperthermia, Induced; Peptides, Cyclic; Sarcoma 180; Verapamil | 1986 |
Reversal of natural resistance to bouvardin (NSC 259968) in sarcoma 180 cells in vitro and in vivo by verapamil.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line; Drug Resistance; Mice; Peptides, Cyclic; Sarcoma 180; Verapamil | 1985 |